Immune Thrombocytopenic Pupura after COVID-19 Vaccine, a Case Report
| Autor: | Eman EL-Sawalhy, Faisal Musa, Raisa Mayers, Maher Khadra, Hafsa Parpia, Samyuktha Madishetty |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Coronavirus disease 2019 (COVID-19)
business.industry Petechial rash Disease medicine.disease Thrombocytopenic purpura Immune system Refractory immune system diseases hemic and lymphatic diseases Immunology General Earth and Planetary Sciences Medicine Rituximab business Mucosal bleeding General Environmental Science medicine.drug |
| Zdroj: | American Journal of Medical Case Reports. 9:394-396 |
| ISSN: | 2374-2151 |
| DOI: | 10.12691/ajmcr-9-8-3 |
| Popis: | Immune Thrombocytopenic Purpura (ITP) is an autoimmune disorder caused by different entities, one of them being the administration of certain vaccines, most commonly MMR vaccines that have been linked with the development of this disease. We report a 26-year-old female presented to the hospital with a petechial rash and mucosal bleeding after three weeks of administration of the COVID-19 vaccine. Thrombocytopenia workup was done, ITP was diagnosed. The ITP in this case was refractory to initial treatment of IVIG and steroid. Rituximab was initiated and she had an excellent response to it. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|